Med Oral Patol Oral Cir Bucal. 2016 Jan 1;21 (1):e127-34. Diclofenac versus meloxicam in oral surgery Journal section: Oral Surgery doi:10.4317/medoral.20925 Publication Types: Research http://dx.doi.org/doi:10.4317/medoral.20925 Single dose of diclofenac or meloxicam for control of pain, facial swelling, and trismus in oral surgery Mariana Orozco-Solís 1, Yazmín García-Ávalos 2, Celeste Pichardo-Ramírez 2, Francisco Tobías-Azúa 2, Juan-Ramón Zapata-Morales 3, Othoniel-Hugo Aragon-Martínez 4, Mario-Alberto Isiordia-Espinoza 5 1 DDS, Departamento de Estomatología, Unidad Médica Familiar No. 02, Instituto Mexicano del Seguro Social, Delegación San Luis Potosí, S.L.P., México 2 DDS, Departamento de Investigación y Postgrado, Escuela de Odontología, Universidad Cuauhtémoc, plantel San Luis Poto- sí, S.L.P., México 3 MSc, PhD, Departamento de Farmacia, División de Ciencias Naturales y Exactas, Universidad de Guanajuato, Guanajuato, México 4 MSc, PhD, Departamento de Farmacología, Facultad de Medicina, Universidad Autónoma de San Luis Potosí, S.L.P., México 5 DDS, MSc, PhD, Departamento de Farmacología, Facultad de Odontología, Universidad Autónoma de Baja California, Mexi- cali, México Orozco-Solís M, García-Ávalos Y, Pichardo-Ramírez C, Tobías-Azúa F, Zapata-Morales JR, Aragon-Martínez OH, Isiordia-Espinoza MA. Single Correspondence: dose of diclofenac or meloxicam for control of pain, facial swelling, and Facultad de Odontología trismus in oral surgery. Med Oral Patol Oral Cir Bucal. 2016 Jan 1;21 Universidad Autónoma de Baja California (1):e127-34. Calle Zotoluca y Chinampas s/n http://www.medicinaoral.com/medoralfree01/v21i1/medoralv21i1p127.pdf Fraccionamiento Calafia C.P. 21040; Mexicali, México Article Number: 20925 http://www.medicinaoral.com/ [email protected] © Medicina Oral S. L. C.I.F. B 96689336 - pISSN 1698-4447 - eISSN: 1698-6946 eMail: [email protected] Indexed in: Science Citation Index Expanded Journal Citation Reports Received: 04/07/2015 Index Medicus, MEDLINE, PubMed Accepted: 19/08/2015 Scopus, Embase and Emcare Indice Médico Español Abstract Background: Postoperative pain associated with removal of mandibular third molars has been documented from moderate to severe during the first 24 hours after surgery, with pain peaking between 6 and 8 hours when a con- ventional local anesthetic is used. Dental pain is largely inflammatory, and evidence-based medicine has shown that nonsteroidal anti-inflammatory drugs are the best analgesics for dental pain. The aim of this study was to compare the analgesic, anti-inflammatory and anti-trismus effect of a single dose of diclofenac and meloxicam after mandibular third molar extraction. Material and Methods: A total of 36 patients were randomized into two treatment groups, each with 18 patients, using a series of random numbers: Group A, was administered 100 mg of diclofenac; and Group B, 15 mg of mel- oxicam. Drugs were administered orally 1 hour prior to surgery. We evaluated pain intensity, analgesic consump- tion, swelling, as well as trismus. Results: The results of this study showed that patients receiving 15 mg of meloxicam had less postoperative pain (P=0.04) and better aperture than those receiving 100 mg of diclofenac (P=0.03). The meloxicam group presented less swelling than diclofenac group; however, significant statistical differences were not observed. Conclusions: Data of this double-blind, randomized, parallel-group clinical trial demonstrated that patients re- ceiving 15 mg of preoperative meloxicam had a better postoperative analgesia and anti-trismus effect compared with who were given 100 mg of diclofenac after third molar extractions. Key words: Diclofenac, meloxicam, dental pain, trismus, third molar surgery. e127 Med Oral Patol Oral Cir Bucal. 2016 Jan 1;21 (1):e127-34. Diclofenac versus meloxicam in oral surgery Introduction ciated up to the day of the surgery, and difficulty of ex- In the majority of cases, removal of third molars will traction (grade II, III, or IV). Exclusion criteria included lead to a significant degree of tissue trauma, causing an use of analgesics 1 week before the procedure, gastritis, inflammatory reaction. The patient develops the com- peptic ulcer, pregnancy or lactation, and known hyper- mon postoperative symptoms and signs of pain, facial sensitivity to the medications used. swelling, dysfunction, and limited mouth opening (tris- - Randomization and blinding mus). The pain is typically brief and will peak in inten- A total of 36 patients from the Department of Maxil- sity in the early postoperative period. Facial swelling lofacial Surgery of the School of Dentistry at Cuauhté- and trismus will reach their characteristic maximum 48 moc University, San Luis Potosí, México, were recruit- to 72 h after surgery (1). ed. The patients were randomized into two treatment Evidence-based medicine has shown that Non-steroidal groups, each with 18 patients, using a series of ran- anti-inflammatory drugs (NSAID) comprise the best dom numbers: Group A, was administered 100 mg of analgesic for dental pain (2). The effects of NSAID are diclofenac; and Group B, 15 mg of meloxicam. Drugs the result of inhibiting Cyclo-oxygenase (COX) en- were administered orally 1 hour prior to surgery. The zymes, which catalyze the conversion of arachidonic algorithm is shown in (Fig. 1). Moreover, both patients acid into prostaglandins, which are fatty acids involved and an independent evaluator were blinded regarding in the generation of pain, inflammation, and fever (3). the treatment administered. Diclofenac is a commonly prescribed NSAID with an- - Interventions algesic, anti-inflammatory, and anti-pyretic properties After the administration of the assigned treatment, the that has been widely used in pain control with good tooth was removed. All of the surgical procedures were effectiveness after third molar surgery (4,5). However, carried out at the Department of Oral and Maxillofacial traditional NSAID such as diclofenac - have been wide- Surgery by the same surgeon. Anesthesia was through ly used to treat pain, but their long term use is limited block of the lingual, buccal, and inferior alveolar nerves by serious gastrointestinal side effects (6). A meta-anal- using two 1.8-mL capsules of 2% lidocaine-containing ysis clearly showed that high-doses of diclofenac (75 mg 1:100,000 epinephrine. Once anesthesia was adminis- twice daily) entails similar vascular risks to the aver- tered, surgery was started. A mucoperiosteal flap was age coxib regimen studied. Absolute excess risks were prepared by making a distal incision to the mandibular small but serious: compared with placebo, allocation to second molar along the anterior edge of the ascending a coxib or to diclofenac caused around three additional ramus of the mandible. This flap was utilized to close major vascular events per 1,000 participants annually, the surgical wound. Suturing was done with 4-0 silk, with one such event causing death (6,7). Meloxicam is and the number of sutures was documented. Difficulty a NSAID of the Oxicam class with selectivity toward of extraction was based on a modified Parant scale as COX-2 compared with COX-1. It is widely used in the follows: Grade I, extraction with forceps and elevators; treatment of osteoarthritis, rheumatoid arthritis, anky- Grade II, extraction by osteotomy; Grade III, extrac- losing spondylitis, and other rheumatological conditions tion by osteotomy and coronal section; and Grade IV, (8). In oral surgery, there are few studies concerning the extraction by osteotomy, root, and coronal section (13). use of meloxicam (8-14). In all cases, the duration of the surgical procedure (from The aim of this pilot study was to compare the analge- incision to final suture) was recorded. In each patient, a sic, anti-inflammatory and anti-trismus effect of a sin- partial impacted mandibular third molar was extracted. gle dose of diclofenac and meloxicam after mandibular - Assessment third molar extraction. The patients were administered 500 mg acetaminophen tablets and were instructed to take one or two pills for Material and Methods postsurgical medication at least 6 hours apart, accord- - Design ing to their requirements. Time of first rescue analgesic This study was designed as a double-blind, randomized, medication, i.e., time from the end of surgery until first parallel-group clinical trial, and was conducted in ac- intake of acetaminophen necessary for the patient, was cordance with the Declaration of Helsinki. The Ethics registered. At the end of the evaluation period (24 hours), Committee approved the study design. All of the sub- the patients returned the unused tablets. The pills were jects were informed of possible risks of oral surgery and counted to determine the number of pills consumed. Pa- experimental treatments, and they signed an institution- tients having no pain relief 30 min after taking 2 aceta- ally approved consent form. minophen tablets orally were given a 30 mg tablet of - Selection criteria sublingual ketorolac as rescue analgesic procedure due Inclusion criteria were age 18-30 years, either sex, free to therapeutic failure. Total analgesic consumption (oral of systemic disease, clinical and radiographic diagnosis acetaminophen and sublingual ketorolac) was evalu- of a mandibular impacted third molar with no pain asso- ated. e128 Med Oral Patol Oral Cir Bucal. 2016 Jan 1;21 (1):e127-34. Diclofenac versus meloxicam in oral surgery Fig. 1. Algorithm showing the progress of subjects through the trial phases. All patients completed the study. A 10 cm Visual Analog Scale (VAS) was employed exact test was employed. A p value <0.05 was consid- to assess pain. The VAS consisted of an interval scale ered a significant statistical difference. ranging from 0, representing no pain or discomfort, to 10, representing maximal pain or discomfort. The VAS Results report was recorded each hour for 12 hours after com- A total of 36 patients were enrolled in the study, and all pletion of surgery, and the last evaluation was conduct- patients were included in the statistical analysis.